Jefferies Group's MRNA Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 95,266 shares of Moderna, Inc. (MRNA) worth $2.46 M, representing 0.01% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 385,291 shares. Largest reduction occurred in Q2 2024, reducing 384,447 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +43,444 | New Buy | 43,444 | $121.50 |
| Q3 2023 | -27,037 | Reduce 62.23% | 16,407 | $103.29 |
| Q4 2023 | +42,155 | Add 256.93% | 58,562 | $99.45 |
| Q1 2024 | +385,291 | Add 657.92% | 443,853 | $106.56 |
| Q2 2024 | -384,447 | Reduce 86.62% | 59,406 | $118.75 |
| Q3 2024 | +80,995 | Add 136.34% | 140,401 | $66.83 |
| Q4 2024 | -60,477 | Reduce 43.07% | 79,924 | $41.58 |
| Q1 2025 | +165,692 | Add 207.31% | 245,616 | $28.35 |
| Q2 2025 | -118,040 | Reduce 48.06% | 127,576 | $27.59 |
| Q3 2025 | -32,310 | Reduce 25.33% | 95,266 | $25.83 |
Jefferies Group's Moderna Investment FAQs
Jefferies Group first purchased Moderna, Inc. (MRNA) in Q2 2023, acquiring 43,444 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Moderna, Inc. (MRNA) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to Moderna, Inc. (MRNA) was in Q1 2024, adding 443,853 shares worth $47.3 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 95,266 shares of Moderna, Inc. (MRNA), valued at approximately $2.46 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Moderna, Inc. (MRNA) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in Moderna, Inc. (MRNA) was 443,853 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.